Class 562/437 - Plural nitrogens

Subclass of Class 562 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the acid contains an additional nitrogen
No. of patents: 182
Last issue date: 06/06/2006

«First «Previous1 2 3 4 5 Next»Last»

Number	Title	Issue Date
7056903	Carboxylic acid derivatives as IP antagonists This invention relates to compounds which are generally IP receptor antagonists and which are represented by Formula I: wherein: R1, R2, and R3 ...	06/06/2006
6888022	Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or i...	05/03/2005
6630512	Cell adhesion inhibitors The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of us...	10/07/2003
6624152	Cell adhesion inhibitors The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of us...	09/23/2003
6596863	Medical composition containing nitroetheneamine Derivative or salt there of as active constituent Process for producing a nitroetheneamine derivative ##STR1## or its stereoisomer, its tautomer or a salt thereof comprising reacting a compound of the formula ##STR2## with a compound of the formula R6 --CH2 NO2 to obtain ...	07/22/2003
6590118	Aromatic compounds Disclosed are compounds of formula I ##STR1## wherein A, R1, R2, R3, R4 and R5 are described in the specification, pharmaceutical formulations comprising these compounds, the use of these compounds are medicaments, the use of these medicaments in the trea...	07/08/2003
6583180	Glucocorticoid receptor modulators Compounds of formula (I) ##STR1## or pharmaceutically acceptable salts thereof are novel glucocorticoid receptor modulators and are useful for treating type II diabetes in a mammal....	06/24/2003
6552216	Molecular model for VLA-4 inhibitors Pharmacophore models of VLA-4 inhibitors, methods of identifying novel inhibitors and novel inhibitors identified by these methods....	04/22/2003
6525025	Gamma-ketoacid dipeptides as inhibitors of caspase-3 This invention encompasses the novel compounds of Formula I, which are useful in the treatment of caspase-3 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions comprising compounds of Formula I as well as methods...	02/25/2003
6462221	Synthesis of nitroalcohol diastereomers The present invention relates to a method of preparing a 1-nitro-3-substituted-3-amino-2-propanol diastereomer represented by Structural Formula I: ##STR1## In Structural Formula I, R is an amine protecting group, and R1 is an amino acid s...	10/08/2002
6451792	Medical composition containing nitroetheneamine derivative or salt thereof as active constituent A medical composition containing, as an active constituent, a nitroetheneamine derivative represented by the formula (I): ##STR1## wherein the substituents are as defined in the disclosure, its stereoisomers, its tautomers or a salt thereof....	09/17/2002
6344483	Halogenated amidino amino acid deviratives useful as nitric oxide synthase inhibitors The current invention discloses halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors, and pharmaceutically acceptable salts thereof....	02/05/2002
6306840	Cell adhesion inhibitors The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of us...	10/23/2001
6284894	Preparation of allylic aromatic compounds A process for the preparation of an allylic aromatic compound in which an aromatic amine is reacted first with a nitrite and then with an allylic olefin having an eliminatable terminal substituent. Novel allylic derivatives of disubstituted benzene compou...	09/04/2001
6284914	Highly water-soluble metalloproteinase inhibitors New compounds of general formulae (III), (IV) and (V). ##STR1##...	09/04/2001
6271416	Quinolinone derivative, method for preparing the same, and anti-allergic agent The present invention relates to a simple method for preparing a quinolinone derivative, which is effective as a medicine, e.g., as an agent for treating allergic diseases and the like; novel amide derivatives effective as an intermediate in the method, n...	08/07/2001
6255277	Localized use of nitric oxide-adducts to prevent internal tissue damage A method for preventing adverse effects associated with the use of a medical device in a patient by introducing into the patient a device of which at least a portion includes a prophylactic or therapeutic amount of a nitric oxide adduct. The nitric oxide ...	07/03/2001
6207708	Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors The current invention discloses hydroxyamidino derivatives useful as nitric oxide synthase inhibitors....	03/27/2001
6177463	Oxime derivatives and their use as pesticides The invention relates to new oxime derivatives, to a plurality of processes for their preparation, and to their use as pesticides....	01/23/2001
6127568	Phenylacetic acid derivatives, preparation thereof and intermediates thereof, and compositions containing them Phenylacetic acid derivatives of the formula I ##STR1## where the substituents and the index have the following meanings: X is NOCH3, CHOCH3, CHCH3 and [sic] CHCH2 CH3 ; R1 is hydrogen and ...	10/03/2000
5981794	γ-oxo-homophenylalanine derivatives and process for producing homophenylalanine derivatives by reducing the same The present invention provides an economically advantageous and efficient process for producing an optically active homophenylalanine derivative of the general formula (IV), and an intermediate therefor and a process for producing it. The present inventio...	11/09/1999
5981795	Method for the N-denitration of N-nitro-dinitroaniline in a homogeneous phase A method of purifying dinitroaniline of the general formula: ##STR1## in which: R is linear or branched C1 -C6 alkyl, C4 -C6 cycloalkyl, C1 -C4 monohaloalkyl or C1 -C4...	11/09/1999
5955505	Glutamic acid receptor agonist A method comprising administering a sulfonamide derivative to a patient requiring activation of glutamate receptors, the sulfonamide derivative represented by the formula ##STR1## wherein A is a napthyl group, a pyridyl group, a phenyl group, a pheny...	09/21/1999
5863947	Phenylglycine derivatives useful for treating disorders of the central nervous system A pharmaceutical compound of the formula: ##STR1## in which R1 is hydrogen, hydroxy or C1-6 alkoxy, R2 is hydrogen, carboxy, tetrazolyl, --SO2 H, --SO3 H, --OSO3 H, --CONHOH, or --P(OH...	01/26/1999
5808003	Polyaminocarboxylate chelators A compound according to the formula: ##STR1## and conjugates thereof....	09/15/1998
5739386	Photolabile compounds and methods for their use Novel compounds are provided which are useful as photocleavable linking groups in solid phase synthesis. Compositions incorporating these linking groups and methods for their use are also described....	04/14/1998
5733342	Hydroxamic acids and hydroxamic acid ethers, and the use thereof as complexing agents Hydroxamic acids and hydroxamic acid ethers I and II ##STR1## where Z1 and Z2 are --NH --OY, --NR1 --OY or --OX, where in the case of (I) at least one of Z1 or Z2, and in the case of (II) Z1...	03/31/1998
5714509	Inhibitors of bacterial sialidase and methods of making and using the same A sialidase inhibitor of the shown formula I: ##STR1## where dashed lines d1 and d2, X1, R1, R2, R6, R3, R4 and R5 are as described in the specificatio...	02/03/1998
5703095	Use of N-arylmethylene, ethylenediaminetriacetates, N-arymethylene iminodiacetates or N,N'-diarylmethylene ethylenediamineacetates against oxidative stress N-arylmethylene ethylenediaminetriacetate, N-arylmethylene iminodiacetate or N,N'-diarylmethylene ethylenediaminediacetate type compounds and their use in combatting oxidative stress, and pharmaceutical and cosmetic compositions comprising said compounds....	12/30/1997
5688945	Compounds The present invention relates to novel derivatives of 3-hydroxyanthranilic acid, 3-HANA, of the general formula I ##STR1## wherein R1 and R2 are the same or different and selected from H and alkyl; X is selected from alkylthio, ...	11/18/1997
5633407	Process for preparing substituted aromatic amines A process for preparing substituted aromatic azo compounds is provided which comprises contacting a nucleophilic compound and an azo containing compound in the presence of a suitable solvent system, and reacting the nucleophilic compound and the azo conta...	05/27/1997
5618979	Process for preparing substituted aromatic amines A process for preparing substituted aromatic amines which comprises contacting a nucleophilic compound and a substituted aromatic azo compound in the presence of a suitable solvent system, and reacting the nucleophilic compound and the substituted aromati...	04/08/1997
5523475	New compounds The present invention relates to novel derivatives of 3-hydroxyanthranilic acid, 3-HANA, of the general formula I ##STR1## wherein R1 and R2 are the same or different and selected from H, alkyl, aryl and arylalkyl; X and Y are t...	06/04/1996
5514716	Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof This disclosure relates to a novel class of hydroxamic and carboxylic acid based matrix metalloproteinase inhibitor derivatives. The disclosure further relates to pharmaceutical compositions containing such compounds and to the use of such compounds and c...	05/07/1996
5495044	Inhibitors of kynureninase The present invention provides inhibitors of kynureninase having the formula ##STR1## where X is CO or CHOH; RA and RB, independently of one another, are H, a halogen, a halovinyl group, or a small alkyl or haloalkyl group ...	02/27/1996
5478835	Tricyclic compounds and intermediates thereof Disclosed is a tricyclic compound represented by the formula (I): ##STR1## wherein each of R1, R2, R3 and R4 independently represents hydrogen, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, amino, C1-6 alkylamin...	12/26/1995
5461045	Fused benzeneoxyacetic acid derivatives A fused benzeneoxyacetic acid derivative of the formula: ##STR1## wherein ##STR2## is (i) ##STR3## (ii) ##STR4## (iii) ##STR5## or (iv) ##STR6## A is (i) ##STR7## or (ii) ##STR8## R1	10/24/1995
5453517	Reactive derivatives of bapta used to make ion-selective chelators The invention relates to fluorescent and/or reactive derivatives of 1,2-bis-(2-aminophenoxyethane)-N,N,N',N'-tetraacetic acid (BAPTA) according to the formula: ##STR1## where at least one of W and X is a functional group, with or without a space...	09/26/1995
5449809	Acetylene derivatives and crop protection agents containing them Acetylene derivatives of the general formula I ##STR1## where U, V and W are hydrogen, halogen, nitro, cyano, alkyl or alkoxy, A is alkylidene, alkoxymethylidene, alkylthiomethylidene or alkoximino, B is OH, alkoxy or alkylamino and R is hydrogen, halogen, cya...	09/12/1995
5430182	Sweetening agent derived from L-aspartic or L-glutamic acid The present invention relates to a novel sweetening agent and to its method of preparation. This novel sweetening agent is a 2-substituted acyl derivative of L-aspartic or L-glutamic acid and has the general formula ##STR1## R being an acyl group of ...	07/04/1995

«First «Previous1 2 3 4 5 Next»Last»

PatentStorm

Quotables

PatentStorm News

Class 562/437 - Plural nitrogens